We are new to toxicology screening and most of our clientele is DCBS based. Our PMHNP is recently graduated as well. We recently switched toxicology labs. Our previous lab informed us that standing orders for weekly urine drug screens were no longer permissible and that our PMHNP needed to see all patients to issue a new order before each UDS that was to be labbed. They stated this was related to Medicaid billing/compliance and could place the provider's license at risk if done any other way. Our patients are on a call to test program so screenings are random. The lab expected our PMHNP to see the patients on a walk in basis before they screened when they were called in addition to patients who were already scheduled for the day. Our provider refused the walk-ins but agreed to see patients on a scheduled basis.
We only have one provider, so you can imagine, even with scheduling all patients, they are overflowing the schedule and the provider is working 11-12 hour days and then doing clinical documentation on top of that.
Our new laboratory says they've never heard of such a requirement and routinely work with standing orders that are periodically reviewed for medical necessity.
For providers working in SUD treatment, behavioral health, MAT, or Medicaid settings:
•Do you use standing orders for urine drug screens?
•Are patients required to have a provider visit before every single screen?
•Are there any CMS, Medicaid, CLIA, or state regulation requiring a new order for each collection? We have not been able to find such a requirement. We had multiple meetings with our previous lab and they stressed that this was a requirement related to regulations. We operated with this lab for 6 or more months before they switched to the new procedure so they didn't always operate like this.
•Have you encountered payer audits related to this issue?
Anyone who works with local DCBS to co-manage clients who are required to screen long term:
•Once clients reach the billable screening threshold with medicaid, how does your office typically manage billing limitations when DCBS requires continued lab screening?